Resistance to neoadjuvant chemotherapy in triple-negative breast cancer mediated by a reversible drug-tolerant stateGloria V. Echeverria, Helen Piwnica‐Worms, Zhongqi Ge et al.|Science Translational Medicine|2019Cited by 316
Regulation of CHK1 by mTOR contributes to the evasion of DNA damage barrier of cancer cellsXinhui Zhou, Changxian Shen|Scientific Reports|2017Cited by 47
Mammary-specific expression of Trim24 establishes a mouse model of human metaplastic breast cancerVrutant Shah, Michelle Barton, Jan Parker‐Thornburg et al.|Nature Communications|2021Cited by 43
Pharmacologic profiling of patient-derived xenograft models of primary treatment-naïve triple-negative breast cancerReid T. Powell, Helen Piwnica‐Worms, Abena B. Redwood et al.|Scientific Reports|2020Cited by 22
Single-cell evaluation reveals shifts in the tumor-immune niches that shape and maintain aggressive lesions in the breastVidya C. Sinha, Helen Piwnica‐Worms, Amanda L. Rinkenbaugh et al.|Nature Communications|2021Cited by 21